These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10790911)

  • 1. Key developments in rheumatology.
    Bacon PA; Allen M
    Practitioner; 1999 Dec; 243(1605):867-71. PubMed ID: 10790911
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there anything else we could possibly need to know about COX-2 selective inhibitor drugs?
    Davis P; Juby A; Robertson S; Richard N
    J Rheumatol; 2004 May; 31(5):847-8. PubMed ID: 15124241
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Joshua FF; Oakley SP; Major GA
    Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonsteroidal antirheumatic agents--present status and perspectives].
    Curković B
    Reumatizam; 2000; 47(2):7-10. PubMed ID: 11552613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Fenn GC; Grobler M; Schaffer D
    Intern Med J; 2004 Nov; 34(11):647-9; discussion 650. PubMed ID: 15546461
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nimesulide: a lower risk treatment in rheumatic diseases].
    Trnavský K
    Vnitr Lek; 2004 Feb; 50(2):157-62. PubMed ID: 15077593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can we treat with modern antirheumatics? Costs of NSAID treatment].
    Bolten WW
    Pharm Unserer Zeit; 2002; 31(2):206-15. PubMed ID: 11977457
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of rheumatic diseases in the elderly.
    Luggen M
    Geriatr Nurs; 2001; 22(3):118-9. PubMed ID: 11410761
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of tumor necrosis factor alpha blockade for enthesitis in spondylarthropathy: comment on the article by Marzo-Ortega et al.
    Olivieri I; Padula A; Scarano E
    Arthritis Rheum; 2002 Dec; 46(12):3396-8; author reply 3398. PubMed ID: 12483753
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
    MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acid coxibs, NO donors, cytokine inhibitors. New beginnings against rheumatism].
    MMW Fortschr Med; 2002 Nov; 144(48):62. PubMed ID: 12532552
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective cyclooxygenase inhibition: promise for future NSAID therapy?
    Fries JF
    Scand J Rheumatol Suppl; 1996; 102():1. PubMed ID: 8628977
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double-blind trial of the effectiveness of antibodies to interferon-gamma and tumor necrosis factor-alpha in rheumatoid arthritis (preliminary results)].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 2001; 73(5):12-5. PubMed ID: 11517739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].
    Glück T; Müller-Ladner U
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1901-4. PubMed ID: 17823884
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs, cyclooxygenase inhibitors, and the risk of gastrointestinal complications.
    Cheskin LJ
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S395-6. PubMed ID: 11570030
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.